Chang-Shi Chen

Chang-Shi Chen

Auto-generated profile, based on publicly available information

Chang-Shi Chen

National Cheng Kung University

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2009 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
ABAudrey Bellier
Audrey Bellier
CCChang-Shi Chen
Chang-Shi Chen
CKCheng-Yuan Kao
Cheng-Yuan Kao
HCHediye N. Cinar
Hediye N. Cinar
RARaffi V. Aroian
Raffi V. Aroian
Pore-forming toxins (PFTs) are by far the most abundant bacterial protein toxins and are important for the virulence of many important pathogens. As such, cellular responses to PFTs critically modulate host-pathogen interactions. Although many cellular responses to PFTs have been recorded, little is understood about their relevance to pathological or defensive outcomes. To shed light on this important question, we have turned to the only genetic system for studying PFT-host interactions—Caenorhabditis elegans intoxication by Crystal (Cry) protein PFTs. We mutagenized and screened for C. elegans mutants resistant to a Cry PFT and recovered one mutant. Complementation, sequencing, transgenic rescue, and RNA interference data demonstrate that this mutant eliminates a gene normally involved in repression of the hypoxia (low oxygen response) pathway. We find that up-regulation of the C. elegans hypoxia pathway via the inactivation of three different genes that normally repress the pathway results in animals resistant to Cry PFTs. Conversely, mutation in the central activator of the hypoxia response, HIF-1, suppresses this resistance and can result in animals defective in PFT defenses. These results extend to a PFT that attacks mammals since up-regulation of the hypoxia pathway confers resistance to Vibrio cholerae cytolysin (VCC), whereas down-regulation confers hypersusceptibility. The hypoxia PFT defense pathway acts cell autonomously to protect the cells directly under attack and is different from other hypoxia pathway stress responses. Two of the downstream effectors of this pathway include the nuclear receptor nhr-57 and the unfolded protein response. In addition, the hypoxia pathway itself is induced by PFT, and low oxygen is protective against PFT intoxication. These results demonstrate that hypoxia and induction of the hypoxia response protect cells against PFTs, and that the cellular environment can be modulated via the hypoxia pathway to protect against the most prevalent class of weapons used by pathogenic bacteria. Bacteria make many different protein toxins to attack our cells and immune system in order to infect. Amongst them, pore-forming toxins (PFTs), which punch holes in the protective plasma membrane that surrounds cells, are by far the most abundant and constitute important virulence factors. Since the integrity of the plasma membrane is fundamental to maintaining the normal intracellular environment, the breaching of the plasma membrane by PFTs results in many and dramatic intracellular responses. However, we know little about the relevance of these responses to cell survival or cell intoxication. Here, using the only genetic system for studying pore-forming toxin effects in a whole animal, we show that the same response that protects cells against low oxygen stress unexpectedly also protects cells against pore-forming toxins. Mutations in the animal that hyper-activate the low oxygen response actually make animals resistant to pore-forming toxin attack, whereas mutations that inactivate the low oxygen response make animals more susceptible. Furthermore, a low oxygen environment itself is protective against pore-forming toxins. These data show a new and powerful connection between low oxygen responses and defense against the single most common mode of bacterial attack.

21 April 2014 in Oncogenesis
Verified
Journal Article
Open access
PDF file
THT-I Hsu
T-I Hsu
CHC-H Hsu
C-H Hsu
KLK-H Lee
K-H Lee
JLJ-T Lin
J-T Lin
CCC-S Chen
C-S Chen
PLPei-Jung Lu
Pei-Jung Lu
MicroRNAs (miRNAs) comprise a class of short, non-coding RNAs that regulate protein synthesis through posttranscriptional modifications. In this study, we found significant upregulation of miR-18a in prostate cancer specimens and prostate cancer cell lines compared with the normal controls. MiRNAs can be separated into two groups based on whether they regulate tumor suppressors or oncogenes. In our previous study, we found that miR-18a, which belongs to the miR17-92 cluster, is upregulated in prostate cancer; the objective of this study was to investigate the associated regulatory mechanisms. We found that miR-18a is upregulated in clinical tumor specimens and cancer cell lines. Our bioinformatics analysis showed that the serine/threonine-protein kinase 4 (STK4) 3′ untranslated region contains a highly conserved binding site for the miR-18a seed region. Luciferase reporter assays were performed to indicate that STK4 is a direct target of miR-18a. Interestingly, miR-18a knockdown decreased cell growth in prostate cancer cells and significantly decreased prostate tumor growth in in vivo nude mice experiments through STK4-mediated dephosphorylation of AKT and thereby inducing apoptosis. Our results suggest that miR-18a acts as an oncomiR targeting STK4 in prostate cancer, and inhibition of miR-18a expression may offer therapeutically beneficial option for prostate cancer treatment.

1 July 2014 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
PDF file
PCP.-L. Chen
P.-L. Chen
CWC.-J. Wu
C.-J. Wu
CCC.-S. Chen
C.-S. Chen
PTP.-J. Tsai
P.-J. Tsai
HTH.-J. Tang
H.-J. Tang
WKWen-Chien Ko
Wen-Chien Ko

1 October 2008 in Biological Control
Verified
Journal Article
Closed access
XLXiang-Qian Li
Xiang-Qian Li
ATAnderson Tan
Anderson Tan
MVMichael Voegtline
Michael Voegtline
SBSenait Bekele
Senait Bekele
CCChang-Shi Chen
Chang-Shi Chen
RARaffi V. Aroian
Raffi V. Aroian

8 January 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RFRu-Huei Fu
Ru-Huei Fu
HHHorng-Jyh Harn
Horng-Jyh Harn
SLShih-Ping Liu
Shih-Ping Liu
CCChang-Shi Chen
Chang-Shi Chen
WCWen-Lin Chang
Wen-Lin Chang
YWYu-Chi Wang
Yu-Chi Wang
Parkinson's disease (PD) is the second most common degenerative disorder of the central nervous system that impairs motor skills and cognitive function. To date, the disease has no effective therapies. The identification of new drugs that provide benefit in arresting the decline seen in PD patients is the focus of much recent study. However, the lengthy time frame for the progression of neurodegeneration in PD increases both the time and cost of examining potential therapeutic compounds in mammalian models. An alternative is to first evaluate the efficacy of compounds in Caenorhabditis elegans models, which reduces examination time from months to days. n-Butylidenephthalide is the naturally-occurring component derived from the chloroform extract of Angelica sinensis. It has been shown to have anti-tumor and anti-inflammatory properties, but no reports have yet described the effects of n-butylidenephthalide on PD. The aim of this study was to assess the potential for n-butylidenephthalide to improve PD in C. elegans models. In the current study, we employed a pharmacological strain that expresses green fluorescent protein specifically in dopaminergic neurons (BZ555) and a transgenic strain that expresses human α-synuclein in muscle cells (OW13) to investigate the antiparkinsonian activities of n-butylidenephthalide. Our results demonstrate that in PD animal models, n-butylidenephthalide significantly attenuates dopaminergic neuron degeneration induced by 6-hydroxydopamine; reduces α-synuclein accumulation; recovers lipid content, food-sensing behavior, and dopamine levels; and prolongs life-span of 6-hydroxydopamine treatment, thus revealing its potential as a possible antiparkinsonian drug. n-Butylidenephthalide may exert its effects by blocking egl-1 expression to inhibit apoptosis pathways and by raising rpn-6 expression to enhance the activity of proteasomes. n-Butylidenephthalide may be one of the effective neuroprotective agents for PD.

1 March 2013 in Experimental Gerontology
Verified
Journal Article
Closed access
YYYa-Luen Yang
Ya-Luen Yang
KLKah-Sin Loh
Kah-Sin Loh
BLBang-Yu Liou
Bang-Yu Liou
I-Hua ChuI-Hua Chu
I-Hua Chu
CKCheng-Ju Kuo
Cheng-Ju Kuo
CCChang-Shi Chen
Chang-Shi Chen